PPT-FDA’s Clinical Investigator Course

Preparing an IND Application CBER Breakout Session Donald W Fink Jr PhD Division of Cellular and Gene Therapies Office of Tissue and Advanced Therapies Center for Biologics Evaluation and Research. Bi. oresearch . Mo. nitoring Program. Jur Strobos MD JD FACEP. Olsson Frank Weeda Terman Matz. jur.strobos@ofwlaw.com. 240-472-9665. BiMo. Investigations. Statutory jurisdiction and penalties. Regulatory scope of inspection and agency remedies. Investigator-Initiated . v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues to be aware of?  . NCURA Western Regional Conference April 5, 2011 – Denver, CO. Challenges . of . FDA-Regulated . Research. Pat Ward & Diane Wilson. UMMS Regulatory Affairs. With special thanks to Kara Morgenstern, HSLO. Human Subject Research at UM. All – Governed by University policy. Investigator-Initiated . v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues to be aware of?  . NCURA Western Regional Conference April 5, 2011 – Denver, CO. of the . Clinical Research . Team. Kathleen O’Malley RN, BSN, CCRP. Manager of Education and Training. Jefferson Clinical Research Institute. Kathleen.omalley@jefferson.edu. Learning Objectives:. Name the required and possible members of the research team. Jan Zolkower, MSHL, CIP, CCRP. January 13, 2012. Review Investigator Responsibilities. Discuss recent FDA Warning letters and OHRP Determination letters. Review of Advanced Notice of Proposed Rulemaking (ANPRM). . Kathy Gilmartin, MSN, CRNP, CCRC. Manager of Clinical Trials Quality Assurance. Background. FDA inspections are typically conducted at clinical sites to determine compliance with federal regulations and adherence to guidelines, to verify the . End of Year Report. Why was the request made:. Bent, Crowley, and Huerfano Counties do not have the expertise or resources to adequately investigate member fraud and settle these cases through repayment agreements or criminal/civil court. . Overview of Good Clinical Practices (GCP) . Investigator and Study Team Responsibilities. Miles McFann. IRB Administration. Training and Outreach. 2. Good Clinical Practice is the compilation of accepted ethical and scientific standards governing clinical research that ensure the integrity of data obtained and the protection of human research subjects.. precision.fda.gov | precisionFDA@fda.hhs.gov | @precisionFDA. Taha A. Kass-Hout, MD, MS. FDA Chief Health Informatics . Officer. Director, FDA’s Office of Health . Informatics. David . Litwack. , PhD. n and Research or CBER conducting clinical research are also referred to as Good Clinical Practices or regulations for nonclinical laboratories compliance regulations during inspections sure that Derita: . dbran@uthsc.edu. Margaret: . mlynn@uthsc.edu. https://tnctsi.uthsc.edu/training-and-education/seminars-and-workshops/tn-ctsi-certification-exam-preparation-course/. Handout/. Reference sheets:. for Strengthening . the . Investigator Site . Community”. Once you’ve logged into WebEx, . please select one of the following . audio options. :. Call Using Computer. I Will Call In. DO NOT SELECT . Presented by the . Research Quality Compliance Network.  . PRESENTERS. Ginger Bair, CCRP – QA/QC Coordinator, Office of Quality Compliance and CTSI. Josh Fessel, MD, PhD . –. . Senior Clinical Advisor, Division of Clinical Innovation, NCATS and NIH.